Member Info for mathsprof

Rightback. Not true. I sold £13k of Mercantile Trust the other day, and the trade was reported an hour late. Its to do with the size of the trade in proportion to the market size trade.

ok ok ... that was inviting the comment that counters are more valuable than VAL shares! But maybe not in the future.

I thought I might buy a few more counters. Very useful in classes!

If all goes to plan, no need for a placing. If there is a placing I suspect 1.5p or less. I have an open mind about it myself, but we have had some tell-tale signs that have come before previous placings. Hence why I sold some last week and I am happy to hold the rest for the time being. 2-way bet, I suppose.

Rock - I doubt very much that the MM care what the price level of a minor AIM stock like Val is. They're not in business to pick up cheap stock. All they want is turnover to make their mark-up.

I doubt whether they has been much panic selling, either. I suspect many think a placing is much more likely than positive news next, and are guessing or already know a sub-2p price is coming. My guess is 1.5p or less if its not this week.

IMHO its not now worth selling at 2p, and I won't be buying more unless the SP drops further.

For what its worth - a tweet from James Mulcair:

Just got a response from suzy it's down to the wording in the application from uk scientific terminology to us, so no need to panic fellas #val #valirx
1 reply 0 retweets 1 like

I don't think we can tell whether the issues are major or advisory. Either way there is delay, because they must resubmit.

Is there a possibility that they could question the statistical basis upon which the results are based, or errors in the appropriateness of calculations? There were certainly some raised questions when the results were first published.

woody - you're not getting the subsequent date from clinicaltrials. Line 2 has not yet appeared. So - "there is not a subsequent date listed for results submitted to ClinicalTrials.gov, this means that the submission is pending changes by the sponsor or investigator."

Maybe its minor or maybe major - I don't know. But I'm worried!

I think the results of P2 we are talking about on clinicaltrials are not the same as what the RNS and George on the interview is talking about, which I think refer to preparations for P3.

The cynical me would suggest the RNS attempts to put a positive position, whist deliberately ignoring the set-back to be published later in the day!

However if there is a problem with the QC review on P2 this will stymie any further progress.

I will expect to see a second line with a new submission date when the issues are sorted out. But no-one will sign any agreement unless and until they are.

On my first post on the thread. Then hover over the I button to read info roses posted.

Have you seen the update on this page of clinicaltrials.gov?

https://clinicaltrials.gov/ct2/show/results/NCT02875340?term=VAL401&draw=1&rank=1

To me this implies that identified issues need to be dealt with before publication on the site. IE further delay. So today's RNS was very much a holding RNS because the real news won't come as soon as we were hoping for.

A bad sign to me, sadly. Perhaps I should have sold more that 150k this morning! Time will tell.

The 8.53 trade is definitely a sell. It was price I was offered at 8.50ish to sell 250k (which I didn't!). Since the SP suddenly jumped at around 8.45 from 2.25-2.5 to 2.5-2.75p I suspect there may still be a much larger buy not yet reported.

The important thing now is that the SP hasn't dropped again, and they still want your shares at just over 2.5p

As for director buys, Noise, was there a last time (except placings?)

I was going to post - the more I try to sell - the higher the SP, but have just noticed a tick up anyway!

No.
The site is run by the US National library of Medicine, and contains many trials from around the world.
Simply a database.

Do you mean this https://clinicaltrials.gov/ct2/show/results/NCT02875340?term=VAL401&draw=1&rank=1

or something else?

Try this https://twitter.com/akw_anthony

and note today's post, too.

Morning C7
Thanks for your comment. I was about to buy in after the placing but missed the boat when the SP went well over 12p in the following weeks. Now there's the retrace - an opportunity again, and the fact its sub 12p now is a real bonus.

There's even an error in the RNS - the price was 11.6p to sell yesterday.

So the question is, is it now a good time to get back into SCLP? (With a bit more than 2483 shares!)

I don't see how any 401 deal can generate any cash for VAL, since 401 is owned by a Valiseek, so cash will belong to Valiseek. (Except a cash offer to buy VAL's interest in Valiseek - unlikely.)

However, what we must hope is that the perceived value of the 55% of Valiseek owned by Valirx will rise enough to give the SP of VAL a decent boost, and hence a platform for a decent fund-raise in late summer.